Genetron Health Welcomes First-Ever Visit from Germany's Renowned German Cancer Research Center
Recently, a delegation of experts from the German Cancer Research Center (DKFZ) at Heidelberg University Hospital, hereinafter referred to as the German Cancer Research Center, visited China.
During this visit, the delegation toured and exchanged insights with several of China’s top oncology medical institutions. As the sole corporate participant, Genetron Health once again garnered recognition and acclaim from internationally authoritative organizations.
Professor Hai Yan, Duke University Chair Professor and Co-founder & Chief Scientific Officer of Genetron Health, warmly welcomed Professor Michael Baumann, Scientific Chair and CEO of the German Cancer Research Center; Professor Josef Puchta, Administrative Director; Professor Eike Otrom Martin, International Relations Coordinator; Professor Webster Cavenee, Member of the U.S. National Academy of Sciences and Director of the Central Nervous System Strategic Alliance at the Ludwig Institute for Cancer Research; and Dr. Sujuan Ba, President and COO of the National Foundation for Cancer Research (NFCR) and Founder & CEO of the Asia Foundation for Cancer Research (AFCR). The two sides engaged in active discussions and exchanges regarding their respective capabilities, research projects, and potential future collaborations.
Experts from the German Cancer Research Center (DKFZ), Affiliated with Heidelberg University, Visit Genetron Health
During this visit to China, the delegation also paid key visits to Beijing Tiantan Hospital of Capital Medical University, Peking University Cancer Hospital, Tianjin Medical University Cancer Institute and Hospital, Fudan University Shanghai Cancer Center, Huashan Hospital of Fudan University, and Ruijin Hospital of Shanghai Jiao Tong University School of Medicine.
About the German Cancer Research Center
The German Cancer Research Center is Germany’s largest biomedical research institution. As one of the most comprehensive and in-depth cancer research institutions in Europe and even globally, it has produced two Nobel laureates in its more than 100 years since establishment.
Currently, the Center comprises more than 90 departments and research groups. Its scientists conduct basic cancer research and scientific exploration to achieve more precise tumor diagnosis, provide better treatment options for cancer patients, and strive to identify effective strategies for cancer prevention and control.
About Genetron Health
As an international enterprise dedicated to precision oncology, Genetron Health operates dual R&D centers in North Carolina, USA, and Beijing, China. By establishing long-term partnerships with two prestigious U.S. cancer research institutions—Duke University and Johns Hopkins University—the company strengthens its foundation in cancer genomics, leverages global scientific resources, and accelerates the clinical translation of innovative cancer diagnosis and treatment technologies both domestically and internationally.
Furthermore, Genetron Health boasts a multidisciplinary team of experts with complementary expertise and collaborates with leading cancer hospitals and research institutions both in China and abroad. The company has published more than ten research papers in prestigious international academic journals, including *Nature Genetics*.
Leveraging its profound expertise in cancer genomics and robust capabilities in scientific research and clinical translation, Genetron Health has attracted visits from numerous internationally renowned research institutions and association experts for exchange and collaboration. Moving forward, Genetron Health will continue to convene top-tier global cancer research talent, working hand in hand to bring greater hope to cancer patients.